Israeli scientists have developed a method of vaccination against melanoma, a type of skin cancer often caused by over-exposure to sunlight.  The vaccine is prepared by removing cells from a melanoma growth. The vaccine is designed to prevent recurrences of the disease amongst previous suffers and to increase chances of survival for current ones.

It was developed by clinical research teams in oncology and dermatology headed by Prof. Tamar Peretz and Dr. Michal Lotem at the Oncology Institute of the Hadassa Medical Center in Jerusalem, whose research was funded by the Israel Cancer Association.